Joanne Curley - Aug 19, 2022 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Signature
/s/ Joseph R. Young, Attorney-in-Fact
Stock symbol
VERA
Transactions as of
Aug 19, 2022
Transactions value $
-$91,959
Form type
4
Date filed
8/23/2022, 04:15 PM
Previous filing
Aug 4, 2022
Next filing
Sep 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Award $0 +12.5K +72.32% $0.00 29.8K Aug 19, 2022 Direct F1
transaction VERA Class A Common Stock Options Exercise $2.41K +378 +1.27% $6.37 30.2K Aug 19, 2022 Direct
transaction VERA Class A Common Stock Sale -$7.14K -378 -1.25% $18.89 29.8K Aug 19, 2022 Direct F2, F3
transaction VERA Class A Common Stock Options Exercise $4.46K +700 +2.35% $6.37 30.5K Aug 19, 2022 Direct
transaction VERA Class A Common Stock Sale -$13.8K -700 -2.3% $19.76 29.8K Aug 19, 2022 Direct F2, F4
transaction VERA Class A Common Stock Options Exercise $2.06K +710 +2.38% $2.90* 30.5K Aug 19, 2022 Direct
transaction VERA Class A Common Stock Sale -$13.4K -710 -2.33% $18.93 29.8K Aug 19, 2022 Direct F2, F5
transaction VERA Class A Common Stock Options Exercise $4.2K +1.45K +4.87% $2.90* 31.2K Aug 19, 2022 Direct
transaction VERA Class A Common Stock Sale -$28.8K -1.45K -4.65% $19.87 29.8K Aug 19, 2022 Direct F2, F6
transaction VERA Class A Common Stock Options Exercise $30.4K +2.77K +9.29% $11.00 32.6K Aug 19, 2022 Direct
transaction VERA Class A Common Stock Sale -$51.5K -2.77K -8.5% $18.61 29.8K Aug 19, 2022 Direct F2, F7
transaction VERA Class A Common Stock Options Exercise $9.94K +904 +3.04% $11.00 30.7K Aug 19, 2022 Direct
transaction VERA Class A Common Stock Sale -$17.9K -904 -2.95% $19.81 29.8K Aug 19, 2022 Direct F2, F8
transaction VERA Class A Common Stock Options Exercise $11.3K +1.03K +3.46% $11.00 30.8K Aug 22, 2022 Direct
transaction VERA Class A Common Stock Sale -$19K -1.03K -3.34% $18.42 29.8K Aug 22, 2022 Direct F2, F9
transaction VERA Class A Common Stock Options Exercise $6.6K +600 +2.01% $11.00 30.4K Aug 22, 2022 Direct
transaction VERA Class A Common Stock Sale -$11.8K -600 -1.97% $19.65 29.8K Aug 22, 2022 Direct F2, F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERA Stock Option (right to buy) Options Exercise $0 -1.08K -7.68% $0.00 13K Aug 19, 2022 Class A Common Stock 1.08K $6.37 Direct F11
transaction VERA Stock Option (right to buy) Options Exercise $0 -2.16K -4.62% $0.00 44.6K Aug 19, 2022 Class A Common Stock 2.16K $2.90 Direct F12
transaction VERA Stock Options (right to buy) Options Exercise $0 -3.67K -3.39% $0.00 105K Aug 19, 2022 Class A Common Stock 3.67K $11.00 Direct F13
transaction VERA Stock Options (right to buy) Options Exercise $0 -1.63K -1.56% $0.00 103K Aug 22, 2022 Class A Common Stock 1.63K $11.00 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under Issuer's 2021 Equity Incentive Plan. One-third of the RSUs vest on August 20, 2023, rounded to the nearest whole share, and the remaining RSUs vest on August 20, 2024, subject to the Reporting Person's continuous service through each vesting date.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022.
F3 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.49 to $19.24, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.56 to $20.00, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F5 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $19.30, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F6 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.70 to $20.02, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F7 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.24 to $19.23, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F8 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.56 to $20.21, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F9 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.20 to $18.75, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F10 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.45 to $19.91, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F11 1/4 of the shares subject to the option vested on March 12, 2021, and 1/48 of the shares vest monthly thereafter.
F12 1/4 of the shares subject to the option vest on December 16, 2021, and 1/48 of the shares vest monthly thereafter.
F13 1/4 of the shares subject to the option vest on May 13, 2022, and 1/48 of the shares vest monthly thereafter.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney